Monday, June 17, 2013
Bankers and buysiders are ready
to declare the first real IPO window since 2000, supported by a good supply of
both high-quality companies and investable cash. Both say the market should
continue to thrive as long as quality companies remain on offer and valuations
So far, the signs are
encouraging. Biotech has out-performed the larger indexes over the past 30
months, finally attracting generalists to the space.